Raffo rebrands as Adium in Argentina
The Argentine drugmaker Raffo has announced a key step in its strategic rebranding, adopting the name Adium in its home country. The company began...
Sinergium to make Pfizer pneumococcal vaccine in Argentina
The US drugmaker Pfizer has signed an agreement with Argentina's Sinergium Biotech for local production of its pneumococcal vaccine Prevenar-20. The deal includes an...
Argentina’s Elea launches Keytruda biosimilar PembroX
Elea is shaking up the market again with another local version of a blockbuster drug. Last year, it launched the "Argentine Ozempic" in the...
Generic of Biogen’s Spinraza launches in Argentina
The Argentine drugmaker Gador has launched a generic Spinraza, a competitor for Biogen's blockbuster spinal muscular atrophy treatment. With the brand name Ligonux, the product...
Oxapharma launches new toxin Clodew
Buenos Aires' iconic opera house, the Teatro Colón, was the stage for last night's launch of a new botulinum toxin for the Argentina market. Clodew,...
Schwintner takes the helm of Servier in Argentina
The local subsidiary of Servier is under new leadership in Argentina. Bruno Schwintner has stepped in after the departure of Nelson Da Conceiçao. The...
Argentina’s Raffo names new managing director
After two decades, Jorge Belluzzo is stepping down as managing director of Argentina's Raffo, part of the Adium group. He'll be replaced by Claudio...
Cytiva leaves Argentina
Macro and micro-economic factors have led Cytiva to exit Argentina. The US company focused on filtration instruments for bioprocesses has stuck a deal with...
Bayer: cuts start in Latam
Bayer has started making cuts in Latin America after its negative Q3 financial results. In Chile, 70% of staff have been laid off. Paraguay,...
Schneider Electric: mission-critical applications
The French digital automation and energy management company Schneider Electric will host a webinar on Tuesday September 26. The meeting will focus on energy...
Argentine pharma faces uncertainty amid devaluation
The devaluation of the Argentine peso following an upset in presidential election primaries on Sunday is causing difficulties for many industries, including the pharmaceutical...
Varifarma loses Octapharma licence
The Argentine drugmaker Varifarma has lost its licence from Octapharma, a Swiss multinational focused on blood products. The products are now licensed to a...
Servier lays off reps in Argentina
The French pharma company Servier has joined the list of multis to strip down their subsidiaries in Argentina. The company behind the vascular protector...
IQVIA World Review: the view for 2023
The pharmaceutical industry met in Buenos Aires today for the traditional annual IQVIA World Review. Various speakers described the current industry panorama at both the...
Paraguay: Scavone group eyes regional expansion
The pharmaceutical industry in Paraguay is developing rapidly, with key players investing to grow both in the country and regionally in Latin America. A...
3M Health Care exits Argentina
The US-based group 3M has taken the decision to stop trading the products from its Health Care business in Argentina. This includes its hospital...
Grifols exits Argentina – full report
Spain's Grifols has abandoned its operations in Argentina. The decision comes amid global cuts following the plasma shortage provoked by the COVID-19 pandemic, which caused...
Argentina says no to heated tobacco productos
Argentina’s Ministry of Health has held up a red card for all devices used as substitutes for traditional tobacco products. Back in 2011, the...
Ferring buys Massone group
The Swiss biopharmaceutical company Ferring has bought the Argentine group Massone and its two two production plants. The group was a local API provider...
Buhl Group now owns Laboratorios Ferrini
The valuation of Argentine brands is routinely affected by the country's import barriers. Now the longstanding local company Laboratorios Ferrini, best known for...
Diaverum bows out in Argentina
Argentina's crumbling social security system continues to weigh on different healthcare subsectors. Now hemodialysis centres have lost another major global player. The Swedish company...
Novartis seals deal with Roemmers
Switzerland's Novartis has already introduced its new combined structure in Argentina. From tomorrow (Friday July 1), local operations will be led by the Australian...
Mundipharma reviews Latin American operations
The British drugmaker Mundipharma, controlled by the US-based Sackler family, has laid off its entire sales force in Argentina. The company is reviewing its...
L’Oréal Argentina: the enemy within
The French cosmetics company L'Oréal lost its focus in Argentina some time ago. But an incident this past week offered more evidence of the...
Novartis makes surprise restructuring
The Swiss drugmaker Novartis surprised its staff with a bombshell today. The company's reversing its dual-pillar structure of Pharma and Oncology divisions, combining the two...
mAbxience: Fresenius buys 55%
Drugmakers built from Argentine capital are rarely come up for sale with shareholders remaining firm against the ups and downs seen at the multis...
Duracell: Genomma replaces Newsan in Argentina
Mexico's Genomma has won the distribution of Duracell in Argentina, bringing an end to the US battery brand's arrangement with local distributor Newsan. Genoma...
Adium to represent Moderna in Latam
Latin America’s Grupo Adium is to represent Moderna in the region. The company, which counts Argentina’s Raffo in its stable, will be the visible...
An end to Osmotica in Argentina
After the entry of North American investors and the Sielecki family having reduced its firepower in the company born on Argentine soil, Osmotica has...
Sandoz signs deal with Butantan in Brazil
Public-private partnerships have become very relevant again in light of the Covid-19 pandemic. Now, Brazil's seen a new agreement in the area of biosimilar...
Amgen makes cuts in Argentina
The US drugmaker Amgen is shrinking its structure internationally, and in Argentina about 20 names have already been cut. The multinational's performance has been hit...
Elly Lilly calls it quits in Argentina
For a second time in its history, the US drugmaker Eli Lilly has decided to close its office in Argentina. The first time was...
Novartis: changes in Argentina
The Swiss drugmaker Novartis has switched up its local management in Argentina. The multi has separated the positions of country president and head of...
Roemmers: deal with BioGaia
The Argentine drugmaker Roemmers continues to add chips to its nutrition business. Now the company has closed a deal with Sweden’s BioGaia to market...
Merck: new CEO in Argentina
A new CEO joins the select number of women at the head of drugmakers in Argentina. María Sol Quibel (39) has taken the helm...
Argentine Congress questions drugmakers
Argentina's Chamber of Deputies, chaired by Sergio Massa, today heard from Nicolás Vaquer, Pfizer's general manager in Argentina, and Marcelo Figueiras, president of the...
Argentina’s Sputnik fill-finish: analysis
Publicity from the president's office broadcast this weekend declared Argentina "the first country in Latin America to produce doses of the vaccine Sputnik V."...
Moderna vaccine advances in Latam
The US drugmaker Moderna is advancing with its landing plan for Latin America. It's brought on board the Argentine Román Saglio, who has strong...
Argentina receives 3.83% of its Latin AZ vaccines
It seems a long time has passed since President Alberto Fernández announced last August in a broadcast shown across all TV channels that Argentina...
Progress with Latin versions of Sputnik V
Despite not having the OK from the regulator ANVISA, Brazil's União Química has gone ahead and produced its first pilot batches of Sputnik V. And it's...
Biosidus pushes interferons for COVID-19
The Biotechnology sector advances slowly but steadily in Argentina, after the recent regulation of the Modern Biotechnology Law. Now the drugmaker Biosidus, owned by...
L’Oréal launches catalogue sales in Argentina
L'Oréal seems to have truly lost its splendour in Argentina. The devaluation of the local currency combined with the impact of the COVID-19 pandemic...
Argentina: media fuss and confusion over vaccines
The daily back and forths behind the manufacturing and representation of COVID-19 vaccines has gripped the media around the world, and Argentina is no...
Argentine version of Cheplapharm’s Questran launches
The Argentine drugmaker Temis Lostaló has received the OK from Argentina’s regulator, ANMAT. The company is launching Nivelipol Resina, its own cholestyramine-based product, putting...
Report: COVID-19 vaccines in Latin America
Regulatory agencies in Latin America continue to march ahead with COVID-19 vaccine approvals. Mexico’s COFEPRIS got the ball rolling when it authorised emergency use...
Argentina OKs Pfizer vaccine for COVID-19
Argentina has just joined the group of countries that have authorised vaccines against COVID-19. The national regulator led by Manuel Limeres has granted authorisation...
Manufacturing cuts at IMAP
Another German company that left Argentina at the end of last year is now generating new cuts in the sector a year later. Half...
Novartis: voluntary redundancies in Argentina
Switzerland's Novartis aims to become a "boutique drugmaker". It's opened negotiations on voluntary redundancies at it looks to downsize its salesforce in Onco-hematology in...
J&J packs up business in Argentina
In November, a third multinational drugmaker will pull out of Argentina. Baxter was the first to go during this year's period of obligatory confinement....
Janssen to trial Covid-19 vaccine in Latam
US giant J&J is one of the host of drugmakers with its foot down on efforts to produce a COVID-19 vaccine. The company, whose...
Change at the top for Sanofi Argentina?
Remote working has become a definitive part of the corporate environment. French drugmaker Sanofi seems to hold that it's as effective to run Argentine...
Sigman to make Covid-19 vaccine in Argentina
A month ago Argentina's president received the local head of Pfizer to announce that the drugmaker would begin clinical trials in Argentina. The...
Catalent to build third Argentine plant
The Softgel specialist Catalent is expanding its capacity in Argentina. Led locally by Hernán Mellone, the company, which dominates the local softgel market, will...
Megalabs brings cannabidiol to Latam
Regulations on the use of treatments based on cannabidiol vary across the region. In Argentina, the use of medicinal oil must be requsted under...
Baxter winds up Argentina operation
The US drugmaker Baxter has closed the doors on its Argentina operation to definitively leave the country. It leaves Argentina's Comarsa as its local representative.
Another...
Pierre Fabre exits Argentina
Several major multinational companies have taken the decision to pull out of Argentina during the Covid-19 lockdown. The airline Latam and the sports brand Nike...
Pfizer hypes Argentina vaccine trial
Pfizer's local general manager Nicolás Vaquer visited the presidential residence in Olivos on what was a holiday weekend in Argentina to tell President Alberto...
Argentina rescinds Spinraza deal
US drugmaker Biogen has had a setback in Argentina. As the country extends its Covid-19 lockdown, the Ministry of Health has removed Obligatory Medical...
Local buyer for Takeda’s Hepatalgina
English version
Argentina's Elea-Phoenix wants to become the main local player in the OTC sector, which has traditionally been dominated by multinationals. It's taken another...
L’Oréal: new head in Argentina
English version
L'Oréal's Argentine operations will be run from the northern hemisphere with a two-hour time difference for the time being as the new local...
Clorox: new general manager for Argentina
English version
The domestic cleaning giant Clorox has a new general manager in Argentina. The man chosen to head up the local branch is Antonio...
Stada offloads Vannier, Argentina
English version:
Germany's Stada was sold a pig in a poke back in 2015, but it didn't take long for the company to notice its...
Lilly: new head in Argentina
English version
Increasing numbers of executives are taking up positions remotely. One case is the new number one at US drugmaker Eli Lilly's Argentine office,...
Biogen under microscope for COVID-19 outbreak
English version
US drugmaker Biogen as well as for Spinraza is now famous as the epicentre of multiple coronavirus cases. In Argentina, its regional director...
Biogen exec COVID-19 green light
English version
US-based Biogen has been one of the drugmakers most affected internationally by the coronavirus pandemic. In Argentina, general manger "Maxi" Gutiérrez has announced...
US drugmaker in local COVID-19 quarantine
English version
The effects of the global coronavirus pandemic have reached Argentina. Most drugmakers are cancelling congresses, conventions and international meetings.
The staff of US drugmaker...
Sidus seals deal with Lifescan
English version
From April 1. Argentine drugmaker Sidus will be the commercial representative of the LifeScan line of blood glucose monitors in Argentina. The brand,...
Megalabs snaps up GSK brands
English version
The Consumer Health sector is seeing continual reorganisation internationally. Joining the list of pharma multinationals who've bought assets only to sell them on...
Takeda sells 18 brands
English version
Since Japan's Takeda acquired Shire in 2018, the drugmaker's course towards a specialist focus has been set. The sale of its portfolio of...
Pfizer CEO in Argentina
English version
Argentina's sky-high inflation isn't stopping the multinationals in the sector. Pfizer's gloval CEO was in the country and even donned the jersey of...
B. Braun opens €30 million plant
English version
Argentina following the rest of the world and has ordered drugmakers to produce parenteral preparations exclusively through closed system technology. To meet the...
Argentina’s Bagó: 2019 «disappointing»
English version
In the event at Hotel Alvear, the group's Juan Carlos Bagó said it would be the last time he presented on stage. He...
Biotoscana changes hands
English version
The big candidate was Brazil's Eurofarma., but Biotoscana has today officially revealed its new owner is the Canadian company Knight Therapeutics. A mayor...
Regulator halts ranitidine production
English version
Argentina's regulator ANMAT is taking measures over ranitidine. On the local market, the leading brand is Taural from Roemmers group, but there are many generics distributed through hospitals and...
Helsinn signs regional deal
English version
Switzerland's Helsinn has closed an agreement with Argentina's Varifarma and Brazil's Blanver for the exclusive licensing and representation of one of its pipeline products in the region. The product in...
3M shuts plants in Argentina
English version
Multinational conglomerate 3M has decided to shut down all three of its Argentine plants including one that manufactures aerosol nebulizers for asthmatics. It will be the first...
Athenex buys CIDAL
English version
The USA's Athenex has announced the acquisition of CIDAL, a Guatemala-headquartered firm focusing on clincal trials and studies that operates in several countries in Latin America.
The CRO (contact research...
Ecuador pharmacies growing
English version
The pharmacy retail sector in Ecuador saw a pivot after the earthquake of 2016. Many sales points have since opened up outside of traditional downtown city centre...
IQVIA in Buenos Aires
English version
The 2019 edition of the IQVIA World Review took place today at a hotel outisde of Buenos Aires, Argentina. Topics included the strengths and weaknesses of...
Sanofi sells Irix and other OTC drugs
English version
La francesa Sanofi has begun to strip itself of products that don't form part of its core earners after having taken a packet of OTC...
Schott invests US $13m
English version
Germany's Schott, a specialist glass maker that produces glass for the pharmaceutical industry Pharmabiz to tour its manufacturing plant in Rio de Janeiro. The company told Pharmabiz that it...
Podcast: the week in English
English Version.
The news from the pharma and cosmetic industry from the second week of March.
A one-minute overview of the news from the pharmaceutical and cosmetic industry by Joseph Foley.
In...
Novartis: end of cardio in Argentina
English version
Swiss drugmaker Novartis is closing the shutters on its cardiometabolic unit in Argentina. As far as Pharmabiz could learn, the mature products Diovan, Galvus and Exforge are being moved...
Cuts at TRB Pharma
English version
Argentina's drugmakers cannot escape the country's recession. Pharmabiz has learned that TRB Pharma has begun crisis prevention measures cutting 10% of its workforce.
Argentina's pharma sector is feeling the...
Novartis CEO in Argentina
English version
The CEO of Novartis is currently in Argentina as part of a Latin American tours that started in Mexico and will wrap up in Sao...
Podcast: the week in English
English Version.
The news from the pharma and cosmetic industry from the second week of February.
A one-minute overview of the news from the pharmaceutical and cosmetic industry by Joseph Foley.
In...
Roemmers buys Bactrim Latam
English version
The Roemmers group has sealed another deal with Swiss drugmaker Roche. It had already bought the company's primary care package in Argentina and now takes on Bactrim and Dormicum for...
Podcast: the week in English
English Version.
The news from the pharmaceutical and cosmetic industry from the first week of February.
A one-minute overview of the news from the pharmaceutical and cosmetic industry by Joseph Foley.
In the podcast...
Unilever launches Nexxus in Argentina
English version
Unilever continues to bring more personal care brands to the Argentine market, now launching Nexxus, a brand that, although in different channels, will compete with L'oréal's Kérastase....
Podcast: the week in English
English Version.
The news from the pharmaceutical industry from the last week of January.
A one-minute overview of the news from the pharmaceutical industry by Joseph Foley.
In the podcast this week, public tenders...
Roemmers group: changes in the region
English version
Argentine pharma group Roemmers is making changes and updating its structure throughout the Latin America region.
Argentine pharma group Roemmers is updating its structure throughout the Latin...
Podcast: the week in English
English Version.
The news from the pharmaceutical industry from the fourth week of January.
A one-minute overview of the news from the pharmaceutical industry by Joseph Foley.
In the podcast this week, Venezuelan pharmacy...
Fraud at Pierre Fabre
English version
French drugmaker Pierre Fabre fired its trade marketing manager in Argentina in December and filed a criminal case in Buenos Aires City. A large quantity of missing...
Podcast: the week in English
The news from the pharmaceutical industry from the third week of January.
English Version.
A one-minute overview of the news from the pharmaceutical industry by Joseph Foley.
This week, businesses and trade unions take...
Inflation in Argentine hygiene, report
English version
Prices across all sectors were continually adjusted throughout 2018. Pharmabiz analyzed the movement of the hygiene and personal care basket monitored by...
Podcast: the week in English
English version.
The news from the pharmaceutical industry from the second week of January.
A one-minute overview of the news from the pharmaceutical industry by Joseph Foley.
This week...
Podcast: the week in English
English Version.
The news from the pharmaceutical industry in the second week of January.
A one-minute overview of pharmaceutical news from the first week of 2019 by...
Podcast: the week in English
A one-minute overview of the news from the pharmaceutical industry in Argentina this Christmas week.
This week, the end of the year for local drugmakers...
Simple launched in Argentina
English version
Unilever launches the brand Simple in Argentina aiming at consumers with sensitive skin with a price point 50% above that of Dove.
Anglo-Dutch giant Unilever continues to launch brands on...
Podcast: the week in English
English version
Our one-minute overview of pharma news in Argentina for the fourth week of November. This week, Roche leaking execs in the country, while...
